The Influence of Prenatal Fumonisin Exposure on Bone Properties,as well as OPG and RANKL Expression and Immunolocalization,in Newborn Offspring Is Sex and Dose Dependent

The current study examined the effects of exposure of pregnant dams to fumonisins (FBs; FB1 and FB2), from the seventh day of pregnancy to parturition, on offspring bone metabolism and properties. The rats were randomly divided into three groups intoxicated with FBs at either 0, 60, or 90 mg/kg b.w. Body weight and bone length were affected by fumonisin exposure, irrespective of sex or dose, while the negative and harmful effects of maternal FBs’ exposure on bone mechanical resistance were sex and dose dependent. The immunolocalization of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-Β ligand (RANKL), in bone and articular cartilage, indicated that the observed bone effects resulted from the FB-induced alterations in bone metabolism, which were confirmed by the changes observed in the Western blot expression of OPG and RANKL. It was concluded that the negative effects of prenatal FB exposure on the general growth and morphometry of the offspring bones, as a result of the altered expression of proteins responsible for bone metabolism, were dose and sex dependent.     

Coumarin-Tagged Dinuclear Trithiolato-Bridged Ruthenium(II)⋅Arene Complexes: Photophysical Properties and Antiparasitic Activity

The synthesis, characterization, photophysical and biological properties of 13 new conjugate coumarin-diruthenium(II)⋅arene complexes against Toxoplasma gondii are presented. For all conjugate organometallic unit/coumarins, an almost complete loss of fluorescence efficacy was observed. However, the nature of the fluorophore, the type of bonding, the presence and length of a linker between the coumarin dye and the ruthenium(II) moiety, and the number of dye units influenced their biological properties. The in vitro activity against a transgenic T. gondii strain grown in human foreskin fibroblasts (HFF) leads to IC₅₀ values for T. gondii β-gal from 105 to 735 nM. Of note is that nine compounds displayed lower IC₅₀ than the standard drug pyrimethamine. One compound applied at its IC₅₀ did not affect B-cell proliferation but had an impact on T-cell proliferation in murine splenocyte cultures. Transmission electron microscopy of T. gondii β-gal-infected HFF showed that treatment predominantly affected the parasites’ mitochondrion.     

Alkene oxidation catalyzed by transition metal substituted Keggin-type heteropolyanions

Alkene oxidations with various oxidants (tert-butyl hydroperoxide, iodosylbenzene and molecular oxygen in the presence of isobutyraldehyde (IBA)) catalyzed by transition metal monosubstituted heteropolyanions, PW₁₁MO ₃₉ ^n– (PW₁₁M; M=Co^II, Mn^II, Cu^II, Ti^IV, Ru^IV, V^V and Nb^V), have been studied. Orders of catalytic activity of PW₁₁M are different for the oxidants studied. Radical chain mechanisms are proposed fort-BuOOH and O₂/IBA. Preliminary coordination of the oxidant to PW₁₁M is not a necessary step of its homolytic activation. Epoxidation with PhIO requires its coordination to the catalyst and most likely includes the formation of active metal-oxo species.     

Specificities of the DMD Gene Mutation Spectrum in Russian Patients

Duchenne/Becker muscular dystrophy (DMD/BMD) is the most common form of muscular dystrophy, accounting for over 50% of all cases. In this regard, in Russia we carry out a program of selective screening for DMD/BMD, which mainly involves male patients. The main inclusion criteria are an increase in the level of creatine phosphokinase (>2000 U/L) or an established clinical diagnosis. At the first stage of screening, patients are scanned for extended deletions and duplications in the DMD gene using multiplex ligase-dependent probe amplification (MLPA SALSA P034 and P035 DMD probemix, MRC-Holland). The second stage is the search for small mutations using a custom NGS panel, which includes 31 genes responsible for various forms of limb-girdle muscular dystrophy. In a screening of 1025 families with a referral Duchenne/Becker diagnosis, pathogenic and likely pathogenic variants in the DMD gene were found in 788 families (in 76.9% of cases). In the current study, we analyzed the mutation spectrum of the DMD gene in Russian patients and noted certain differences between the examined cohort and the multi-ethnic cohort. The analysis of the DMD gene mutation spectrum is essential for patients with DMD/BMD because the exact mutation type determines the application of a specific therapeutic method.     

Cytokine Profiling in Different SARS-CoV-2 Genetic Variants

This study is a successor of our previous work concerning changes in the chemokine profile in infection that are associated with different SARS-CoV-2 genetic variants. The goal of our study was to take into account both the virus and the host immune system by assessing concentrations of cytokines in patients infected with different SARS-CoV-2 variants (ancestral Wuhan strain, Alpha, Delta and Omicron). Our study was performed on 340 biological samples taken from COVID-19 patients and healthy donors in the timespan between May 2020 and April 2022. We performed genotyping of the virus in nasopharyngeal swabs, which was followed by assessment of cytokines’ concentration in blood plasma. We noted that out of nearly 30 cytokines, only four showed stable elevation independently of the variant (IL-6, IL-10, IL-18 and IL-27), and we believe them to be ‘constant’ markers for COVID-19 infection. Cytokines that were studied as potential biomarkers lose their diagnostic value as the virus evolves, and the specter of potential targets for predictive models is narrowing. So far, only four cytokines (IL-6, IL-10, IL-18, and IL-27) showed a consistent rise in concentrations independently of the genetic variant of the virus. Although we believe our findings to be of scientific interest, we still consider them inconclusive; further investigation and comparison of immune responses to different variants of SARS-CoV-2 is required.     

Positron Annihilation Study of Zirconia Nanopowders and Nanoceramics Stabilized by Magnesia and Ceria

Positron lifetime (LT) and coincidence Doppler broadening (CDB) measurements on nanopowders and ceramics of ceria‐ and magnesia‐stabilized zirconia (CeSZ and MgSZ, respectively) are presented. The nanopowders were prepared by the coprecipitation technique. Effects of nanopowder calcination and sintering at various temperatures were investigated. In the nanopowders, the two kinds of open‐volume defects associated with grain boundaries (GBs) could be identified via positron trapping: (i) vacancy‐like misfit defects situated along GBs and (ii) larger defects at the intersections of at least three GBs (triple points). CDB measurements on CeSZ compacted nanopowders indicated a segregation of Ce ions along GBs. A few percent fractions of positrons were found to form positronium localized in pores of ≈1.8 nm diameter in compacted nanopowders. Sintering of nanopowders at 1500°C appeared to be sufficient for disappearance of pores and triple point defects. In sintered ceramics, contrary to compacted nanopowders, positrons were trapped in zirconium vacancies in grain interiors.